Facing up to the ongoing challenge of Kaposi's sarcoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (43)
PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
2013 • 790 citations
British HIV Association guidelines for HIV‐associated malignancies 2008
2008 • 230 citations
Malignancies in HIV/AIDS
2014 • 214 citations
Trends in the incidence of cancer in Kampala, Uganda 1991-2010
2013 • 183 citations
Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010
2013 • 176 citations
Randomized Phase II Trial of Matrix Metalloproteinase Inhibitor COL-3 in AIDS-Related Kaposi's Sarcoma: An AIDS Malignancy Consortium Study
2006 • 161 citations
A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa
2012 • 139 citations
Diagnosis and management of lymphomas and other cancers in HIV-infected patients
2014 • 126 citations
Prospective Stage-Stratified Approach to AIDS-Related Kaposi's Sarcoma
2013 • 125 citations
Incidence and Timing of Cancer in HIV-Infected Individuals Following Initiation of Combination Antiretroviral Therapy
2013 • 119 citations
Phase II Study of Bevacizumab in Patients With HIV-Associated Kaposi's Sarcoma Receiving Antiretroviral Therapy
2012 • 110 citations
Risk of AIDS-Defining Cancers Among HIV-1–Infected Patients in France Between 1992 and 2009: Results From the FHDH-ANRS CO4 Cohort
2013 • 109 citations
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma
2013 • 107 citations
The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era
2013 • 106 citations
The relationship between area poverty rate and site‐specific cancer incidence in the United States
2014 • 102 citations
Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042
2013 • 99 citations
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma
2009 • 96 citations
Incidence of <scp>AIDS</scp>‐defining cancers and virus‐related and non‐virus‐related non‐<scp>AIDS</scp>‐defining cancers among <scp>HIV</scp>‐infected patients compared with the general population in a large health district of northern <scp>I</scp>taly, 1999–2009
2013 • 72 citations
Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection
2013 • 65 citations
Sirolimus for the Treatment of Kaposi Sarcoma After Renal Transplantation: A Series of 10 Cases
2012 • 63 citations
Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention
2013 • 61 citations
Rapamycin With Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma
2011 • 59 citations
Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study
2014 • 58 citations
Kaposi's Sarcoma in HIV‐infected patients in South Africa: Multicohort study in the antiretroviral therapy era
2014 • 58 citations
Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma
2007 • 52 citations
Clinical characteristics and outcomes of HIV‐infected children diagnosed with kaposi sarcoma in malawi and botswana
2013 • 47 citations
Malignancies in South African Children With HIV
2014 • 47 citations
The management of children with Kaposi sarcoma in resource limited settings
2012 • 40 citations
Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon
2014 • 40 citations
Racial and Ethnic Disparities in the Incidence and Trends of Soft Tissue Sarcoma Among Adolescents and Young Adults in the United States, 1995–2008
2013 • 33 citations
Kaposi’s sarcoma in children: An open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin
2014 • 32 citations
Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy
2014 • 28 citations
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy
2012 • 25 citations
Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011
2013 • 25 citations
Clinical outcomes of <scp>HIV</scp>‐infected patients with <scp>K</scp>aposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor‐based antiretroviral therapy in <scp>U</scp>ganda
2011 • 22 citations
Treatment of Kaposi sarcoma in children with HIV-1 infection
2014 • 20 citations
Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm3at presentation
2013 • 20 citations
Drug–drug interactions in HIV positive cancer patients
2014 • 20 citations
Clinical Activity of Lenalidomide in Visceral Human Immunodeficiency Virus–Related Kaposi Sarcoma
2013 • 14 citations
Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS–Kaposi’s sarcoma
2013 • 12 citations
Peginterferon Alfa-2a for AIDS-Associated Kaposi Sarcoma: Experience With 10 Patients
2013 • 11 citations
Isolated penile Kaposi’s sarcoma in a HIV-positive patient stable on treatment for three years
2014 • 10 citations
The Use of Monoclonal Antibodies to Treat Castleman‘s Disease
2014 • 4 citations
Cited By (0)
No citing papers found in database